Biotrend Cevre ve Enerji Yatirimlari AS
Biotrend Cevre ve Enerji Yatirimlari AS is an independent power and renewable electricity producer operating in the utilities sector, generating revenue primarily through the production and sale of electricity.
Business. Biotrend Cevre ve Enerji Yatirimlari AS (BIOEN.IS) is a Turkish electric utility company engaged in the utilities sector. The firm is headquartered in Turkey and primarily listed on the Borsa Istanbul. Specific details regarding its operating segments and geographic revenue mix are not available.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Peers
- EarningsQ3 2026 earnings (expected)2026-10-28 · estimated · Duke Energy (DUK)
- EarningsQ3 2026 earnings (expected)2026-10-28 · estimated · NextEra Energy (NEE)
- EarningsQ3 2026 earnings (expected)2026-10-28 · estimated · Southern Company (SO)
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Biotrend Cevre ve Enerji Yatirimlari AS (BIOEN.IS) is a Turkish electric utility company engaged in the utilities sector. The firm is headquartered in Turkey and primarily listed on the Borsa Istanbul. Specific details regarding its operating segments and geographic revenue mix are not available.
Biotrend Cevre ve Enerji Yatirimlari AS has a market capitalization of 8.53 billion TRY and a price-to-book ratio of 3.06, indicating that the market values the company at a premium to its book value. The company's liquidity position is characterized as medium risk, with a current ratio of 0.31, suggesting that it has limited short-term liquidity to cover its immediate liabilities. The company's cash and equivalents amount to 52.29 million TRY, which is significantly lower than its long-term debt of 5.21 billion TRY, resulting in a negative net cash position.
The company's profitability is weak, with a net loss of 1.38 billion TRY and an operating loss of 627.47 million TRY in the latest reporting period. Its return on equity is -49.57%, and its return on assets is -14.28%, both of which are significantly below the industry median for Electric Utilities. The company's gross profit of 99.85 million TRY is insufficient to cover its operating expenses, contributing to the negative operating income.
Biotrend Cevre ve Enerji Yatirimlari AS operates in a single business segment, and its geographic exposure is concentrated in Turkey, as disclosed in its financial statements. The company's revenue is entirely derived from this region, which may expose it to local economic and regulatory risks. There is no indication of revenue diversification across multiple geographic regions or business lines.
The company's growth trajectory is uncertain, with no specific revenue growth projections provided in the latest financial data. However, the company's capital expenditure of 578.75 million TRY indicates ongoing investment in its operations. The free cash flow is negative at -1.06 billion TRY, which may limit the company's ability to fund future growth initiatives without external financing.
The company faces several risk factors, including a high debt-to-equity ratio of 1.87, which increases its financial leverage and exposes it to potential liquidity constraints. The risk assessment indicates a low probability of dilution, but the company's negative net cash position and high leverage could necessitate future equity or debt financing, which may lead to dilution. The company's operating cash flow of 701.99 million TRY provides some buffer against short-term obligations, but it is insufficient to cover the long-term debt.
There are no recent events or filings disclosed in the latest data that would significantly impact the company's operations or financial position. The company's financial statements do not indicate any material changes in its business strategy or operational performance in the most recent reporting period.
- Biotrend Cevre ve Enerji Yatirimlari AS is valued at a premium to book value, with a price-to-book ratio of 3.06.
- The company is experiencing significant financial losses, with a net loss of 1.38 billion TRY and an operating loss of 627.47 million TRY.
- The company's liquidity position is weak, with a current ratio of 0.31 and a negative net cash position.
- The company's growth trajectory is uncertain, with no clear revenue growth projections and a negative free cash flow.
- The company's high debt-to-equity ratio of 1.87 increases its financial leverage and exposes it to liquidity risks.
- The company's operations are concentrated in Turkey, which may expose it to local economic and regulatory risks.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Ev To Operating Cash Flowenterprise_value / operating_cash_flow
- Return On Equitynet_income / total_equity
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- Biotrend Cevre ve Enerji Yatirimlari AS Market data — financials · 2026-05-27